Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specifications
| Brand name | METOPROLOL SUCCINATE |
| Generic name | METOPROLOL SUCCINATE ER TABLETS |
| Active ingredient(s) | METOPROLOL SUCCINATE |
| Distributed by / for | Ascend Laboratories, LLC, Parsippany, NJ 07054 |
| NDC | 67877-590-01 |
| Full product label | Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-590-01. |
| Recalling firm | Ascend Laboratories, LLC |
| Distribution | U.S. Nationwide |
| Quantity | 17,304 100-count bottles |
| Recall initiated | 2026-04-27 |
| Report date | 2026-05-20 |
| Recall completed | — |
| Recall number | D-0547-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Bedminster NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗